<DOC>
	<DOCNO>NCT00560313</DOCNO>
	<brief_summary>This study aim evaluate safety , tolerability immunogenicity three dos Novartis 4CMenB one dose Novartis Meningococcal ACWY vaccine administer healthy at-risk adult .</brief_summary>
	<brief_title>Safety , Tolerability Immunogenicity Three Doses Novartis Meningococcal B Vaccine When Administered Healthy At-risk Adults</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Lactitol</mesh_term>
	<criteria>Healthy adults,18 50 year age , might routinely expose N. meningitidis culture Previous ascertain suspected disease cause N. meningitidis ; Pregnancy breastfeeding ; History anaphylactic shock , asthma , urticaria allergic reaction previous vaccination know hypersensitivity vaccine component ; Any present suspect serious acute chronic disease Known suspect autoimmune disease impairment /alteration immune function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Meningococcal disease</keyword>
	<keyword>prevention</keyword>
	<keyword>vaccination</keyword>
</DOC>